Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G L Griffiths

Showing results (31-40 of 56) with videos related to

Pageof 6
Sort By:
International Journal of Cancer|June 11, 1999
Cytotoxicity with Auger electron-emitting radionuclides delivered by antibodiesG L Griffiths, S V Govindan, G Sgouros, et al.
Cancer Research|December 1, 1995
Bacterial expression of a kemptide fusion protein facilitates 32P labeling of a humanized, anti-carcinoembryonic antigen (hMN-14) antibody fragmentS O Leung, H Karacay, M J Losman, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 1, 1995
Engineering a unique glycosylation site for site-specific conjugation of haptens to antibody fragmentsS Leung, M J Losman, S V Govindan, et al.
Nuclear Medicine Communications|May 11, 1999
Intracellular processing of 99Tcm-antibody conjugatesH Karacay, G L Ong, H J Hansen, et al.
Cancer|February 1, 1994
Processing of antibody-radioisotope conjugates after binding to the surface of tumor cellsM J Mattes, G L Griffiths, H Diril, et al.
Cancer Research|December 1, 1995
Site-specific modifications of light chain glycosylated antilymphoma (LL2) and anti-carcinoembryonic antigen (hImmu-14-N) antibody divalent f1agmentsS V Govindan, D M Goldenberg, G L Griffiths, et al.
Cancer Research|September 11, 1991
Direct radiolabeling of monoclonal antibodies with generator-produced rhenium-188 for radioimmunotherapy: labeling and animal biodistribution studiesG L Griffiths, D M Goldenberg, F F Knapp, et al.
Bioconjugate Chemistry|November 23, 2000
Experimental pretargeting studies of cancer with a humanized anti-CEA x murine anti-[In-DTPA] bispecific antibody construct and a (99m)Tc-/(188)Re-labeled peptideH Karacay, W J McBride, G L Griffiths, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 30, 1999
Targeting human cancer xenografts with monoclonal antibodies labeled using radioiodinated, diethylenetriaminepentaacetic acid-appended peptidesR Stein, S V Govindan, M J Mattes, et al.
Critical Reviews in Oncology/Hematology|June 22, 2001
Successful therapy of a human lung cancer xenograft using MAb RS7 labeled with residualizing radioiodineR Stein, S V Govindan, S Chen, et al.
Pageof 6

Showing results (31-40 of 56) with videos related to

Sort By:
Pageof 6
International Journal of Cancer|June 11, 1999
Cytotoxicity with Auger electron-emitting radionuclides delivered by antibodiesG L Griffiths, S V Govindan, G Sgouros, et al.
Cancer Research|December 1, 1995
Bacterial expression of a kemptide fusion protein facilitates 32P labeling of a humanized, anti-carcinoembryonic antigen (hMN-14) antibody fragmentS O Leung, H Karacay, M J Losman, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 1, 1995
Engineering a unique glycosylation site for site-specific conjugation of haptens to antibody fragmentsS Leung, M J Losman, S V Govindan, et al.
Nuclear Medicine Communications|May 11, 1999
Intracellular processing of 99Tcm-antibody conjugatesH Karacay, G L Ong, H J Hansen, et al.
Cancer|February 1, 1994
Processing of antibody-radioisotope conjugates after binding to the surface of tumor cellsM J Mattes, G L Griffiths, H Diril, et al.
Cancer Research|December 1, 1995
Site-specific modifications of light chain glycosylated antilymphoma (LL2) and anti-carcinoembryonic antigen (hImmu-14-N) antibody divalent f1agmentsS V Govindan, D M Goldenberg, G L Griffiths, et al.
Cancer Research|September 11, 1991
Direct radiolabeling of monoclonal antibodies with generator-produced rhenium-188 for radioimmunotherapy: labeling and animal biodistribution studiesG L Griffiths, D M Goldenberg, F F Knapp, et al.
Bioconjugate Chemistry|November 23, 2000
Experimental pretargeting studies of cancer with a humanized anti-CEA x murine anti-[In-DTPA] bispecific antibody construct and a (99m)Tc-/(188)Re-labeled peptideH Karacay, W J McBride, G L Griffiths, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 30, 1999
Targeting human cancer xenografts with monoclonal antibodies labeled using radioiodinated, diethylenetriaminepentaacetic acid-appended peptidesR Stein, S V Govindan, M J Mattes, et al.
Critical Reviews in Oncology/Hematology|June 22, 2001
Successful therapy of a human lung cancer xenograft using MAb RS7 labeled with residualizing radioiodineR Stein, S V Govindan, S Chen, et al.
Pageof 6